FIELD: molecular biology, genetic engineering, polypeptides, medicine.
SUBSTANCE: in using the double-hybrid yeast system DNA sequences encoding polypeptides (55.1 and 55.3) have been found that elicit ability for binding with intracellular domain p-55 (p-55IC) of TNF-receptor. It has been established that these polypeptides represent fragments of amino acid sequences p-55IC, respectively, from 338 to 426 and from 277 to 426 residues. As result of insertion of DNA fragments with a sequence encoding polypeptide 55.1 or 55.3 into the structure of expressing vector and transformation suitable host-cells by this vector recombinant form of indicated polypeptides have been prepared. Using this invention provides the possibility for modulating the function of intact p-55 of TNF-receptor. Invention can be used in medicine in treatment of diseases associated with transfer of TNF-signal.
EFFECT: improved preparing method and valuable properties of polypeptide.
9 cl, 17 dwg, 3 tbl, 6 ex
Title |
Year |
Author |
Number |
DNA MOLECULE ENCODING POLYPEPTIDE ABLE TO BIND WITH INTRACELLULAR DOMAIN OF FAS (FAS-IC) LIGAND RECEPTOR, POLYPEPTIDE, METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATION OF EFFECT OF FAS-R LIGAND ON CELLS (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEIN |
1995 |
- Uollakh Dehvid
- Boldin Mark
- Varfolomeev Evgenij
- Mett Igor'
|
RU2241747C2 |
DNA SEQUENCE ENCODING POLYPEPTIDE THAT BINDS WITH MORT-1 (VARIANTS), POLYPEPTIDE (VARIANTS) AND METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATING LIGAND FAS-R OR TNF EFFECT ON CELLS (VARIANTS), METHOD FOR TREATMENT OF CELLS, METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEINS, METHOD FOR MODULATING MORT-1-INDUCED EFFECT OR MORT-1-BINDING PROTEIN-INDUCED EFFECT ON CELLS |
1996 |
- Vollakh Dehvid
- Boldin Mark
- Goncharov Tanja
- Gol'Tsev Jurij
|
RU2235779C2 |
METHOD OF HETEROLOGICAL POLYPEPTIDE PURIFICATION |
2004 |
- Lester Filip M.
- Persson Dzhozefin
|
RU2337968C2 |
MAT40 ANTIBODY BINDING WITH DOMAIN I OF EXTRACELLULAR PART OF EPIDERMAL HER2/CD340 GROWTH FACTOR RECEPTOR, AND ITS APPLICATION FOR CANCER TREATMENT |
2015 |
- Zaripov Mikhail Makhmudovich
- Afanaseva Gajda Vladislavovna
- Glukhov Anatolij Sergeevich
- Glukhova Kseniya Alekseevna
- Trizna Yuliya Aleksandrovna
- Prusakova Olga Vadimovna
- Beletskij Igor Petrovich
|
RU2640259C2 |
FACTOR EFFECTING ON ACTIVITY OF TUMOR NECROSIS FACTOR RECEPTOR-RELEASING ENZYME |
1999 |
- Gatanaga Tetsuja
- Grehndzher Gejl A.
|
RU2279478C2 |
IMMUNOGLOBULIN POLYPEPTIDE, ITS FRAGMENT, COMPOSITION, STRAIN OF HYBRID CULTURED CELLS, METHOD OF POLYPEPTIDE PREPARING |
1992 |
- Ramakrishnan Vanita
- Ehskobedo Marija A.
- Fretto Lehrri Dzh.
|
RU2194760C2 |
TRANSDUCIBLE POLYPEPTIDES FOR MITOCHONDRIAL METABOLISM MODIFICATION |
2009 |
|
RU2529950C2 |
IMMUNOCONJUGATE, A METHOD OF AN IMMUNOCONJUGATE PREPARING AND A PHARMACEUTICAL COMPOSITION |
1994 |
- Ilka Fon Khegen
- Uve Khofmann
- Karlotta-Sil'Vija Eggle
- Vol'Fgang Shtrittmatter
- Jorg Shtadl'Mjuller
- Zigfrid Mattsku
|
RU2129018C1 |
METHODS OF APPLYING OF APO-2L-RECEPTORS AGONISTS AND NK-CELLS ACTIVATORS |
2005 |
- Godovski Pol Dzh.
- Satial Sandzhiv Kh.
|
RU2395294C2 |
CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS |
2015 |
|
RU2764074C2 |